ICC/IF
Immunofluorescence analysis of Hela cells using MEF2D antibody (green). Blue: DAPI fluorescent DNA dye. Red: Actin filaments have been labeled with Omnimabs® 594-Phalloidin.| Product Name | Anti-MEF2D antibody-AF488 |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Polypeptide |
| Conjugation | AF488 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Symbol | MEF2D |
|---|---|
| Gene Synonyms | MEF2D Myocyte-specific enhancer factor 2D |
| Gene Full Name | myocyte enhancer factor 2D |
| Gene Summary | This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012] |
| Alternative Names | DKFZp686I1536 MADS box transcription enhancer factor 2 polypeptide D MEF2D/DAZAP1 fusion transcription factor transcription factor muscle-specific isoform |
| Molecular Weight(MW) | 56kDa(observed：67kDa) |
| Source | Rabbit |
| Cellular Localization | Nucleus |
| SwissProt ID | Q14814 |
|---|
ICC/IF
Immunofluorescence analysis of Hela cells using MEF2D antibody (green). Blue: DAPI fluorescent DNA dye. Red: Actin filaments have been labeled with Omnimabs® 594-Phalloidin.| Form | Liquid |
|---|---|
| Storage Instructions | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle. |
| Storage Buffer | Purified antibody in PBS with 0.05% PC300,40% Glycerol. |
